Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia.
about
Ghrelin for the management of cachexia associated with cancerLoss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatmentPathophysiology of anorexia in the cancer cachexia syndromeCancer as a Proinflammatory Environment: Metastasis and CachexiaUnderstanding cachexia as a cancer metabolism syndromeGhrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved.Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male miceGhrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerationsRegulation of ghrelin structure and membrane binding by phosphorylation.Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profileProtein calorie malnutrition, nutritional intervention and personalized cancer care.Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) TumorsAssociation of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation.Clinical development of ghrelin axis-derived molecules for cancer cachexia treatmentSafety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover studyEvaluation of ghrelin level and appetite regulation in patients with acute exacerbations of chronic obstructive pulmonary disease.The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer.Ghrelin gene products in acute and chronic inflammation.Emerging markers of cachexia predict survival in cancer patients.Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndromeCancer cachexia, mechanism and treatmentGhrelin for cachexia.Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia.Nutritional interventions for cancer-induced cachexiaWeight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity.Anorexia in cancer: role of feeding-regulatory peptides.Rikkunshito, a traditional Japanese medicine, suppresses cisplatin-induced anorexia in humansPotentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.Use of ghrelin in cachexia syndrome: a systematic review of clinical trials.Acylation of ghrelin is increased in heart failure and decreases post heart transplantation.Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model.Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients.Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia.Predicting survival in cancer patients: the role of cachexia and hormonal, nutritional and inflammatory markers.Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility.Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in ratsRole of ghrelin in the pathophysiology of gastrointestinal disease.β1-Adrenergic receptor deficiency in ghrelin-expressing cells causes hypoglycemia in susceptible individuals.Role of the duodenum in regulation of plasma ghrelin levels and body mass index after subtotal gastrectomy.
P2860
Q26471773-167E9D14-0E26-4178-B3E8-8748974F6133Q26775254-272C3187-D439-4FE2-85CA-892A2BE80F6BQ26775294-FE98AAD4-6690-4F61-82FD-397FA31C1451Q26778324-7BC0087C-CE97-4E37-B6EA-1E4AAC153EBBQ28069390-D4EB8E14-6C99-4D10-9C71-C3730E269E19Q30384810-E49039C4-50B6-4E61-A8D9-376E5C9E1238Q30410972-C7631155-DF2D-42EA-B2F5-380C16AC0F3BQ30426403-B121D1E6-FCA1-4311-BE4D-81AF90DFF0F1Q30431058-14EA8E81-D4C7-4057-9964-2AEAA1A056BEQ30439568-E4CFEBA4-9B61-4112-AA48-3D59A8651A9FQ30440296-A07B857A-7686-44E3-9A17-21BE7CA64571Q33618955-BCF70ED3-A936-4703-820C-F9249F89D7F4Q33755034-0211DFED-C0C8-490D-88DB-CAEC99C10AE4Q33872067-1765D87F-B507-4885-91CA-8C8C7E42031BQ34002674-0CD72505-7636-4504-8BDF-4A167D94AC9CQ34009312-86354CB4-D68D-4CCA-AF84-0966BE29EF2DQ34073543-B3471645-A84F-4149-995F-5AA85AC05AEAQ34198587-39A07E25-E038-4DDE-9148-CA4F974C0606Q34414977-C244B36D-A133-4903-8C3D-6E3391B52220Q34551579-7FD5A7BC-0423-411F-A004-1ED15E9B4A69Q34669261-B0967DEF-0ADF-423B-96B8-29B20A137E36Q34669440-463C0751-04F5-4FDF-9D91-6F940A1AE61EQ34697171-85B52316-757F-42B8-BC07-5F0261AC7B06Q34697244-59BB65DA-DDBD-4223-8882-000E855E100CQ35019743-772E61B9-3841-4FC7-AD73-F0A2A6F87084Q35136210-9B27A1B3-9D40-41E3-82CE-B3944CC09274Q35140230-5193C003-2DF3-40AF-922B-57E1A83D57FCQ35662036-E32A9D92-B3FF-4696-90B8-F5B3F96715D9Q35844223-5275BBB4-D14E-4E5B-B4B3-D377058F68ADQ36165843-4D556FEA-7487-4E58-BA2F-BEE7CED3F172Q36277093-20940E37-83FC-43D3-BF18-CCF233520ABEQ36294093-80F0D7FF-A09C-4554-B25C-7370D9BCDFFBQ36349348-B24DA2D2-6B92-4614-A36C-692F6E20CE17Q36415811-9767F795-9F00-49A6-B106-348CB6B8CCABQ36421066-179B0256-E271-4531-AE04-29942FA833BDQ36502957-9B7DAE32-2878-4B07-8396-0101F9A197CEQ36805444-4BC414F6-62CF-4A94-A615-8A8BA590EACDQ37196453-6EE32B70-68CA-4B04-A443-2F065C240267Q37217540-618D7C42-4614-4343-99AA-FC281E399C14Q37248780-C34523E4-0A20-4FCB-8368-871A6077D215
P2860
Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia.
@ast
Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia.
@en
type
label
Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia.
@ast
Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia.
@en
prefLabel
Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia.
@ast
Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia.
@en
P2093
P356
P1476
Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia.
@en
P2093
Daniel Epner
George Taffet
Glenn R Cunningham
Josè M Garcia
Marco Marcelli
Mariana Garcia-Touza
Rabih A Hijazi
Roy G Smith
P304
P356
10.1210/JC.2004-1788
P407
P577
2005-02-15T00:00:00Z